Upstate Active Clinical Trials
Study Title:An Open-Label, Expanded Access Protocol for Firdapse® (Amifampridine Phosphate; 3,4-Diaminopyridine Phosphate) Treatment in Patients with Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndromes (CMS) and Downbeat Nystagmus
What is the purpose of the study?The purpose of this study is to allow your doctor to use amifampridine tablets to treat your disease symptoms.
Upstate Institutional Review Board (IRB) Number:777408
Study/Protocol ID:PROTOCOL NO: EAP-001
Study Phase:PHASE IV
Patient Age Group:Adults and Children
Principal Investigator:Deborah Y Bradshaw
What is involved if I participate?
- How long is the study?
Until study drug is approved and becomes available by prescription
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
Informed Consent, Physical Examination, Neurological Examination, Vital Signs, Medication Review, Medical History Review, Clinical Laboratory Tests, Electrocardiogram
Other Information:Contact: Muhammad M. Iqbal
Phone: (315) 464 - 1814
Who can I contact for more information?
Name: Muhammad M Iqbal